MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Kinetic–rest tremor polarity for differentiating dystonic tremor and Parkinson’s disease

    T. Tsuboi, T. Uematsu, M. Hashida, Y. Ito, K. Sawada, M. Higuchi, T. Ishizaki, T. Tsugawa, S. Maesawa, K. Fuse, Y. Saito, T. Fukushima, D. Tamakoshi, K. Hiraga, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)

    Objective: To characterize ordinal patterns of tremor amplitude across rest, postural, and kinetic conditions in dystonic tremor (DT) and Parkinson's disease (PD) using accelerometry, and…
  • 2026 International Congress

    Beyond Freezing of Gait Episodes in Parkinson’s Disease: Intercritical Kinematic Gait Pattern Matters.

    G. de Biasi, F. Di Filippo, L. Santos, C. Ricciardi, M. Russo, N. Pisani, MC. Calabrese, M. Romano, M. Picillo, R. Erro, MT. Pellecchia, P. Barone, M. Amboni (Salerno, Italy)

    Objective: To search for features discriminating different gait patterns during intercritical FOG-free phases in patients with anamnestic FOG, using spatiotemporal and kinematic variables and machine…
  • 2026 International Congress

    Efficacy and Safety of Mesdopetam (IRL790) for Levodopa Induced Dyskinesia in Parkinson’s Disease: A Meta analysis of Randomized Controlled Trials

    A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the efficacy and safety of mesdopetam compared with placebo for levodopa‑induced dyskinesia (LID) in Parkinson’s disease (PD). Background: Mesdopetam (IRL790) is a…
  • 2026 International Congress

    Intestinal Dysbiosis in Parkinson’s Disease: Mechanisms, Clinical Implications, and Therapeutic Perspectives (2015–2025)

    H. Harifi (Kenitra, Morocco)

    Objective: This narrative review aims to consolidate research published from 2015 to 2025 regarding abnormalities in gut microbiota in patients with Parkinson’s disease, emphasizing potential…
  • 2026 International Congress

    Risk of Deep Venous Thrombosis in Patients With Parkinson’s Disease: A Meta‑Analysis of Observational Studies

    V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To compare the risk of deep venous thrombosis (DVT) in patients with Parkinson’s disease (PD) versus non‑PD. Background: Patients with PD may have an…
  • 2026 International Congress

    Tongue Fasciculations in Amyotrophic Lateral Sclerosis Compared Between Electromyography and Transoral Ultrasonography

    N. Iijima, Y. Hagiwara, Y. Yamano (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: To compare the detection of tongue fasciculations between electromyography (EMG) and transoral motion-mode ultrasonography (TOMU) in patients with amyotrophic lateral sclerosis (ALS), and to…
  • 2026 International Congress

    Accessible Assessment of Ataxia Severity Across Diverse Populations: Integrating Large Datasets, Machine-Learning, and Online Testing

    T. Gilad, A. Lithwick Algon, S. Yamnitsky, P. Ponger, J. Hausdorff, W. Saban (Tel Aviv, Israel)

    Objective: To explore whether internet-based assessments combined with machine learning approaches can support scalable characterization of ataxia severity. Background: In-person assessments of ataxia severity are…
  • 2026 International Congress

    Efficacy of Vitamin C for Restless Legs Syndrome: A Systematic Review and Meta‑analysis of Randomized Controlled Trials

    A. Fornari Caprara, J. Pitton Rissardo, J. Patino, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To evaluate the efficacy and safety of vitamin C (VITC) for treating restless legs syndrome (RLS) using evidence exclusively from randomized controlled trials (RCTs).…
  • 2026 International Congress

    Rare Variant Analysis in Parkinson’s Disease Patients Stratified by Polygenic Risk

    S. Kanagasingam, A. Balan, Z. Gan-Or, K. Senkevich (Montréal, Canada)

    Objective: To identify rare variants that may contribute to Parkinson’s disease (PD) risk in individuals whose polygenic background does not adequately explain their disease status.…
  • 2026 International Congress

    Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To compare the efficacy and safety of tetrabenazine, deutetrabenazine, and valbenazine for chorea and neuropsychiatric outcomes in Huntington’s disease (HD). Background: Vesicular monoamine transporter…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley